Lincoln Pharmaceuticals Ltd Q1 FY2022-23 consolidated profit up QoQ at Rs. 15.01 crores

Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 129.9655 crores during the period ended June 30, 2022 as compared to Rs. 104.4777 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 15.0115 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 11.0241 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 7.49 for the period ended June 30, 2022 as compared to Rs. 5.50 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 129.9655 crs	₹104.4777 crs	24.40%
Net Profit	₹15.0115 crs	₹11.0241 crs	36.17%
EPS	₹7.49	₹5.50	36.18%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 129.9655 crores during the period ended June 30, 2022 as compared to Rs.124.1995 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.15.0115 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.17.7027 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.7.49 for the period ended June 30, 2022 as compared to Rs.8.84 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 129.9655 crs	₹124.1995 crs	4.64%
Net Profit	₹15.0115 crs	₹17.7027 crs	-15.20%
EPS	₹7.49	₹8.84	-15.27%

Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 309.50 as compared to the previous close of Rs. 314.50. The total number of shares traded during the day was 2135 in over 169 trades.

The stock hit an intraday high of Rs. 343.00 and intraday low of 307.70. The net turnover during the day was Rs. 669276.00.

Source : Equity Bulls

Keywords

LincolnPharmaceuticals Q1FY23 ResultUpdate